Durvalumab vs Fluconazole

Durvalumab vs Fluconazole: Overview

This comparison examines the pharmacological differences between Durvalumab and Fluconazole.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Fluconazole: Inhibits fungal CYP51 (lanosterol 14-alpha-demethylase).

Pharmacokinetics

Half-life: Durvalumab — 17 days; Fluconazole — 30 hours.

Chemical Properties

Molecular Formula: Fluconazole — C13H12F2N6O.

Molecular Weight: Fluconazole — 306.2710 g/mol.

Type: Durvalumab — Antibody; Fluconazole — Small molecule.